ANIMALCARE GROUP PLC (ANCR) — Interim Results 2024

Investor webinar replay

Replay transcript excerpt

Good morning, and welcome to the ANIMALCARE GROUP PLC interim results investor presentation. Throughout this recorded presentation, investors will be in listen only mode. Questions are encouraged, they can be submitted at any time by the q and a tab situated in the right corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives through the meeting itself. Have the company camera view all the questions that have been submitted today and publish responses where it is appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to CEO, Jenny Winter. Good morning. Good morning. And welcome to this is the second of the series of of these presentations we're doing. So delighted to share with you our interim results up to the end of June twenty twenty four. There's myself, the CEO, and Chris Brewster, and we'll try and handle any questions. We'll walk through the presentation and hopefully that answers some of the questions you may have as we go through. But as Alexandra says, do feel free to add questions onto the q and a session. So oh, sorry. My dog's my dog's going to eat an eat an invader. So just for those of you who aren't that familiar with animal care, we've just popped in a slide to make sure that we we share with you a little bit about ourselves. So we are listed on AIM. We're an international veterinary pharmaceutical sales marketing organization. And what we focus on is bringing new and innovative products to market through both our own development pipeline, partnerships with third parties, but also by acquisitions. And we'll talk a little bit more about that. We actually operate in seven countries. When we talk about operatin...